FULC
Fulcrum Therapeutics, Inc. · Healthcare
Director Robert J Gould sold $578K of Fulcrum Therapeutics, Inc.
Sold$577,895
$8.09Price
71,435Shares
−12%Stake
What FULC did after the filing
- The stock from Wed, Jun 8 close, $8.30
- −32.4%
- S&P 500, same days
- −3.5%
Measured over 30 trading days, to the Jul 22 close.
Traded Tue, Jun 7. Filed Wed, Jun 8, 3:33 PM ET, during the session. Returns use the Jun 8 close and the Jul 22 close. Not investment advice.